This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Cutaneous, Ocular, and Neurologic Abnormalities in 830 Published Cases

Kenneth H. Kraemer, MD; Myung M. Lee; Joseph Scotto, MS

Arch Dermatol. 1987;123(2):241-250.

Abstract
• Quantitative frequencies of clinical abnormalities in xeroderma pigmentosum were estimated by abstracting published descriptions of 830 patients in 297 articles obtained from a survey of the medical literature from 1874 to 1982. The median patient age was 12 years with nearly equal numbers of male and female patients. Cutaneous symptoms (sun sensitivity or freckling) had a median age of onset of between 1 and 2 years. Forty-five percent of the patients described had basal cell carcinoma or squamous cell carcinoma of the skin. The median age of first nonmelanoma skin cancer among patients with xeroderma pigmentosum was 8 years, more than 50 years less than that among patients with skin cancer in the United States. Melanomas were reported in 5% of patients. Ninety-seven percent of the reported basal and squamous cell carcinomas and 65% of the melanomas in patients with xeroderma pigmentosum occurred on the face, head, or neck. Seventy percent probability of survival was attained at age 40 years, a 28-year reduction in comparison with the US general population. Ocular abnormalities were reported in 40% of the patients described and were restricted to tissues exposed to ultraviolet radiation (lid, conjunctiva, and cornea) and included ectropion, corneal opacity leading to blindness, and neoplasms. Neurologic abnormalities were found in 18% of the cases reported, consisting of progressive mental deterioration, hyporeflexia or areflexia, and progressive deafness in some patients in association with dwarfism and immature sexual development. There was scant information concerning the efficacy of any therapeutic regimen.

(Arch Dermatol 1987;123:241-250)

Author Affiliations
From the Laboratory of Molecular Carcinogenesis (Dr Kraemer and Mr Lee) and the Biostatistics Branch (Mr Scotto), National Cancer Institute, Bethesda, Md. Mr Lee is now with Northwestern University School of Medicine, Chicago.

Footnotes
Accepted for publication Aug 18, 1986.

Reprint requests to the National Cancer Institute, Bldg 37, Room 3E24, Bethesda, MD 20892 (Dr Kraemer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Christen-Zaech et al.
Arch Dermatol 2009;145:1285-1291.
ABSTRACT | FULL TEXT  

Checkpoint Kinase ATR Promotes Nucleotide Excision Repair of UV-induced DNA Damage via Physical Interaction with Xeroderma Pigmentosum Group A
Shell et al.
J. Biol. Chem. 2009;284:24213-24222.
ABSTRACT | FULL TEXT  

Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas
Wang et al.
Proc. Natl. Acad. Sci. USA 2009;106:6279-6284.
ABSTRACT | FULL TEXT  

Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations
Faghri et al.
J. Med. Genet. 2008;45:609-621.
ABSTRACT | FULL TEXT  

Neurological symptoms and natural course of xeroderma pigmentosum
Anttinen et al.
Brain 2008;131:1979-1989.
ABSTRACT | FULL TEXT  

Neurodegeneration in xeroderma pigmentosum
Taylor
Brain 2008;131:1967-1968.
FULL TEXT  

Thiothymidine plus low-dose UVA kills hyperproliferative human skin cells independently of their human papilloma virus status
Reelfs et al.
Molecular Cancer Therapeutics 2007;6:2487-2495.
ABSTRACT | FULL TEXT  

High-Mobility Group A1 Proteins Inhibit Expression of Nucleotide Excision Repair Factor Xeroderma Pigmentosum Group A
Adair et al.
Cancer Res. 2007;67:6044-6052.
ABSTRACT | FULL TEXT  

Attenuated Expression of Xeroderma Pigmentosum Group C Is Associated with Critical Events in Human Bladder Cancer Carcinogenesis and Progression
Chen et al.
Cancer Res. 2007;67:4578-4585.
ABSTRACT | FULL TEXT  

Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.
Arlett et al.
Br. J. Radiol. 2006;79:510-517.
ABSTRACT | FULL TEXT  

Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients
Khan et al.
Carcinogenesis 2006;27:84-94.
ABSTRACT | FULL TEXT  

Proficient Global Nucleotide Excision Repair in Human Keratinocytes but not in Fibroblasts Deficient in p53
Ferguson and Oh
Cancer Res. 2005;65:8723-8729.
ABSTRACT | FULL TEXT  

Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study
Blankenburg et al.
Carcinogenesis 2005;26:1085-1090.
ABSTRACT | FULL TEXT  

Gene transduction in skin cells: Preventing cancer in xeroderma pigmentosum mice
Marchetto et al.
Proc. Natl. Acad. Sci. USA 2004;101:17759-17764.
ABSTRACT | FULL TEXT  

Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes
Arbault et al.
Carcinogenesis 2004;25:509-515.
ABSTRACT | FULL TEXT  

Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice
Goukassian et al.
Proc. Natl. Acad. Sci. USA 2004;101:3933-3938.
ABSTRACT | FULL TEXT  

Case 7-2004 - A 48-Year-Old Woman with Multiple Pigmented Lesions and a Personal and Family History of Melanoma
Tsao et al.
NEJM 2004;350:924-932.
FULL TEXT  

Fine Mapping of Chromosome 3 in Uveal Melanoma: Identification of a Minimal Region of Deletion on Chromosomal Arm 3p25.1-p25.2
Parrella et al.
Cancer Res. 2003;63:8507-8510.
ABSTRACT | FULL TEXT  

NRAS Hypermutability in Familial Melanoma With CDKN2A Mutations--Cause and Effect?
Kraemer
JNCI J Natl Cancer Inst 2003;95:768-769.
FULL TEXT  

Role of DNA Polymerase {eta} in the UV Mutation Spectrum in Human Cells
Stary et al.
J. Biol. Chem. 2003;278:18767-18775.
ABSTRACT | FULL TEXT  

Inter-individual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers
Vogel et al.
Carcinogenesis 2002;23:1505-1509.
ABSTRACT | FULL TEXT  

The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
Khan et al.
Nucleic Acids Res 2002;30:3624-3631.
ABSTRACT | FULL TEXT  

RAD1 Controls the Meiotic Expansion of the Human HRAS1 Minisatellite in Saccharomyces cerevisiae
Jauert et al.
Mol. Cell. Biol. 2002;22:953-964.
ABSTRACT | FULL TEXT  

Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin invitro
Bernerd et al.
Proc. Natl. Acad. Sci. USA 2001;98:7817-7822.
ABSTRACT | FULL TEXT  

The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms
Emmert et al.
Nucleic Acids Res 2001;29:1443-1452.
ABSTRACT | FULL TEXT  

Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis
Ide et al.
Carcinogenesis 2001;22:567-572.
ABSTRACT | FULL TEXT  

Cutaneous Squamous-Cell Carcinoma
Alam and Ratner
NEJM 2001;344:975-983.
FULL TEXT  

Association between DNA Repair-deficiency and High Level of p53 Mutations in Melanoma of Xeroderma Pigmentosum
Spatz et al.
Cancer Res. 2001;61:2480-2486.
ABSTRACT | FULL TEXT  

Cockayne syndrome and xeroderma pigmentosum: DNA repair disorders with overlaps and paradoxes
Rapin et al.
Neurology 2000;55:1442-1449.
ABSTRACT | FULL TEXT  

Association Between INK4a-ARF and p53 Mutations in Skin Carcinomas of Xeroderma Pigmentosum Patients
Soufir et al.
JNCI J Natl Cancer Inst 2000;92:1841-1847.
ABSTRACT | FULL TEXT  

Mutations in the XPC Gene in Families with Xeroderma Pigmentosum and Consequences at the Cell, Protein, and Transcript Levels
Chavanne et al.
Cancer Res. 2000;60:1974-1982.
ABSTRACT | FULL TEXT  

Ultraviolet B Radiation-induced Skin Cancer in Mice Defective in the Xpc, Trp53, and Apex (HAP1) Genes: Genotype-specific Effects on Cancer Predisposition and Pathology of Tumors
Cheo et al.
Cancer Res. 2000;60:1580-1584.
ABSTRACT | FULL TEXT  

The Cancer-free Phenotype in Trichothiodystrophy Is Unrelated to Its Repair Defect
Berneburg et al.
Cancer Res. 2000;60:431-438.
ABSTRACT | FULL TEXT  

Frequencies of hprt- mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records
Bentham et al.
Mutagenesis 1999;14:527-532.
ABSTRACT | FULL TEXT  

The Pathogenesis of Melanoma Induced by Ultraviolet Radiation
Gilchrest et al.
NEJM 1999;340:1341-1348.
FULL TEXT  

Differential Behaviors toward Ultraviolet A and B Radiation of Fibroblasts and Keratinocytes from Normal and DNA-Repair-deficient Patients
Otto et al.
Cancer Res. 1999;59:1212-1218.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma and Melanoma: Etiological Similarities and Differences
Miller and Rabkin
Cancer Epidemiol. Biomarkers Prev. 1999;8:153-158.
ABSTRACT | FULL TEXT  

Mutational Inactivation of the Xeroderma Pigmentosum Group C Gene Confers Predisposition to 2-Acetylaminofluorene-induced Liver and Lung Cancer and to Spontaneous Testicular Cancer in Trp53-/- Mice
Cheo et al.
Cancer Res. 1999;59:771-775.
ABSTRACT | FULL TEXT  

Polymorphisms in the DNA Repair Gene XPD: Correlations with Risk and Age at Onset of Basal Cell Carcinoma
Dybdahl et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:77-81.
ABSTRACT | FULL TEXT  

DNA repair disorders • Commentary
Woods
Arch. Dis. Child. 1998;78:178-184.
FULL TEXT  

A 28-Year-Old Fair-Skinned Woman With Multiple Moles
Robinson
JAMA 1997;278:1693-1699.
ABSTRACT  

In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in Xeroderma pigmentosum patients
Reardon et al.
Proc. Natl. Acad. Sci. USA 1997;94:9463-9468.
ABSTRACT | FULL TEXT  

Malignant Melanoma in Children: A Review
Ruiz-Maldonado and de la Luz Orozco-Covarrubias
Arch Dermatol 1997;133:363-371.
ABSTRACT  

Large Congenital Melanocytic Nevi and the Risk for the Development of Malignant Melanoma: A Prospective Study
Marghoob et al.
Arch Dermatol 1996;132:170-175.
ABSTRACT  

Melanoma in Children
Ceballos et al.
NEJM 1995;332:656-662.
FULL TEXT  

The Role of Sunlight and DNA Repair in Melanoma and Nonmelanoma Skin Cancer: The Xeroderma Pigmentosum Paradigm
Kraemer et al.
Arch Dermatol 1994;130:1018-1021.
ABSTRACT  

Sunlight Avoidance and Cancer Prevention in Xeroderma Pigmentosum
Davis et al.
Arch Dermatol 1994;130:806-808.
ABSTRACT  

Gene Alterations and Clinical Characteristics of Xeroderma Pigmentosum Group A Patients in Japan
Nishigori et al.
Arch Dermatol 1994;130:191-197.
ABSTRACT  

Controlling Malignant Melanoma: A Focus on Pediatricians
Brodkin and Altman
Arch Pediatr Adolesc Med 1993;147:875-881.
ABSTRACT  

Isotretinoin Does Prevent Skin Cancer
Kraemer et al.
Arch Dermatol 1993;129:43-43.
ABSTRACT  

Xeroderma Pigmentosum Variant With Multisystem Involvement
Hessel et al.
Arch Dermatol 1992;128:1233-1237.
ABSTRACT  

A Case of Xeroderma Pigmentosum Group A Diagnosed With a Polymerase Chain Reaction (PCR) Technique: Usefulness of PCR in the Detection of Point Mutation in a Patient With a Hereditary Disease
Kore-eda et al.
Arch Dermatol 1992;128:971-974.
ABSTRACT  

Host Factors, UV Radiation, and Risk of Uveal Melanoma: A Case-Control Study
Seddon et al.
Arch Ophthalmol 1990;108:1274-1280.
ABSTRACT  

The Epidemic of Squamous Cell Carcinoma
Weinstock
JAMA 1989;262:2138-2140.
ABSTRACT  

Malignant Melanoma of the Iris in Xeroderma Pigmentosum
Johnson et al.
Arch Ophthalmol 1989;107:402-407.
ABSTRACT  

Reduced DNA Repair in Cultured Melanocytes and Nevus Cells From a Patient With Xeroderma Pigmentosum
Kraemer et al.
Arch Dermatol 1989;125:263-268.
ABSTRACT  

A 32P-Postlabeling Assay for the Oxidative DNA Lesion 8,5'-Cyclo-2'-deoxyadenosine in Mammalian Tissues. EVIDENCE THAT FOUR TYPE II I-COMPOUNDS ARE DINUCLEOTIDES CONTAINING THE LESION IN THE 3' NUCLEOTIDE
Randerath et al.
J. Biol. Chem. 2001;276:36051-36057.
ABSTRACT | FULL TEXT  

Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients
Broughton et al.
Proc. Natl. Acad. Sci. USA 2002;99:815-820.
ABSTRACT | FULL TEXT  

The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts
Emmert et al.
Proc. Natl. Acad. Sci. USA 2000;97:2151-2156.
ABSTRACT | FULL TEXT  

Differential role of transcription-coupled repair in UVB-induced G2 arrest and apoptosis in mouse epidermis
van Oosten et al.
Proc. Natl. Acad. Sci. USA 2000;97:11268-11273.
ABSTRACT | FULL TEXT